TALPHERA, INC. Payments of Debt Restructuring Costs
TALPHERA, INC. (TLPH) reported Payments of Debt Restructuring Costs of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtRestructuringCosts · last filed 2021-03-15
- TALPHERA, INC. payments of debt restructuring costs for the quarter ending 2020-12-31 was $0.00.
- TALPHERA, INC. payments of debt restructuring costs for the quarter ending 2020-09-30 was $0.00.
- TALPHERA, INC. payments of debt restructuring costs for the quarter ending 2019-12-31 was $0.00.
- TALPHERA, INC. payments of debt restructuring costs for the quarter ending 2019-09-30 was $0.00.
- TALPHERA, INC. payments of debt restructuring costs for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- TALPHERA, INC. payments of debt restructuring costs for fiscal 2019 was $190.00K.
- TALPHERA, INC. payments of debt restructuring costs for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- TALPHERA, INC. payments of debt restructuring costs for fiscal 2017 was $204.00K, a 0.49% decline from fiscal 2016.
| Period end | Payments of Debt Restructuring Costs 3 month | Payments of Debt Restructuring Costs 6 month | Payments of Debt Restructuring Costs 9 month | Payments of Debt Restructuring Costs 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $0.00 derived: sum of 2 quarters · filed 2021-03-15 | $0.00 10-K · filed 2021-03-15 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | ||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $0.00 derived: sum of 2 quarters · filed 2021-03-15 | $190.00K 10-K · filed 2021-03-15 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $190.00K 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $190.00K 10-Q · filed 2020-08-10 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-15 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $204.00K 10-K · filed 2020-03-16 | ||
| 2017-09-30 | $204.00K 10-Q · filed 2018-11-05 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $205.00K 10-K · filed 2019-03-07 | ||
| 2016-09-30 | $205.00K 10-Q · filed 2017-11-09 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $215.00K 10-K · filed 2018-03-09 | ||
| 2015-09-30 | $215.00K 10-Q · filed 2016-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |